Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Sunitinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 18 Gastrointestinal Stromal Tumors 10 Neoplasms 5 Neoplasm Metastasis 4 Multiple Myeloma 4 Kidney Neoplasms 4 Urologic Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Meningioma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Kidney Diseases 2 Gastrointestinal Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Adenoma, Islet Cell 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Solid Tumors Refractory to Standard Therapy 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1

Interventions

Dexamethasone 16 Lenalidomide 14 Bortezomib 11 Cyclophosphamide 9 fludarabine 7 Melphalan 7 carfilzomib 6 Whole-Body Irradiation 6 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 fludarabine phosphate 4 pomalidomide 3 gamma-Globulins 3 belantamab mafodotin 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Radiotherapy 3 elotuzumab 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Granulocyte Colony-Stimulating Factor 2 Etoposide 2 Ciprofloxacin 2 Amoxicillin-Potassium Clavulanate Combination 2 venetoclax 1 thymoglobulin 1 siltuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡